Covariate-adjusted borrowing of historical control data in randomized clinical trials.

about

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

Item

http://www.wikidata.org/entity/Q36385882

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

@ast

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

@en

type

Item

label

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

@ast

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

@en

prefLabel

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

@ast

Covariate-adjusted borrowing of historical control data in randomized clinical trials.

@en

P1476

Covariate-adjusted borrowing of historical control data in randomized clinical trials

@en

P2093

Dawei Liu

http://www.w3.org/2001/XMLSchema#string

Jia Zhan

http://www.w3.org/2001/XMLSchema#string

Stacy Lindborg

http://www.w3.org/2001/XMLSchema#string

Z John Zhong

http://www.w3.org/2001/XMLSchema#string

P2860

The BUGS project: Evolution, critique and future directions

Adaptive adjustment of the randomization ratio using historical control data.

Use of historical control data for assessing treatment effects in clinical trials.

Semiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical data

Bayesian approach for flexible modeling of semicompeting risks data

COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL DATA SOURCES IN ONCOLOGY USING GENERALIZED MIXTURE COMMENSURATE PRIORS.

Meta-analysis of continuous outcomes combining individual patient data and aggregate data.

Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models.

The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.

The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee.

P304

296-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PST.1815

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Baoguang Han

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28560815

http://www.w3.org/2001/XMLSchema#string

P921

covariate